Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Protocol to Redefine Muscle Attenuation Cut-offs for Better Prediction of Mortality in Patients With Cirrhosis: a Comprehensive Post-hoc Validation Study

NCT06593015 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT06593015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06593015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Protocol to Redefine Muscle Attenuation Cut-offs for Better Prediction of Mortality in Patients With Cirrhosis: a Comprehensive Post-hoc Validation Study
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
February 2, 2024
Enrollment
1,296 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, malnutrition, myosteatosis, portal hypertension related to cirrhosis, sarcopenia, sarcopenia in liver cirrhosis